Email this article Self-control as prevention of cardiovascular disease
- Authors: Manuylova Y.A1
-
Affiliations:
- I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 7, No 2 (2016)
- Pages: 60-63
- Section: Articles
- URL: https://journals.rcsi.science/2221-7185/article/view/45272
- DOI: https://doi.org/10.26442/CS45272
- ID: 45272
Cite item
Full Text
Abstract
Diabetes mellitus is a common problem with high levels of morbidity and mortality. Economic costs of treating the disease and its complications are very high. Diabetic complications arise with chronic hyperglycaemia in the case of hypoglycemia. Prevention of these conditions contributes to the maintenance of normoglycemia, what a crucial role it plays an adequate self-control. Precise instruments for measuring blood glucose at home with minimal errors make it possible to take measures to achieve a compensation of the disease, thereby preventing the occurrence of acute and late complications, improving the quality and duration of life for the patient and reducing the cost of its treatment.
Full Text
##article.viewOnOriginalSite##About the authors
Yu. A Manuylova
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Email: juliakolish@yahoo.com
канд. мед. наук, ассистент каф. эндокринологии, врач-эндокринолог УКБ №2 ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia d. 8, str. 1
References
- Khaw K.T, Wareham N, Bingham S et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European Prospective Investigation in to Cancerin Norfolk. Ann Intern Med 2004; 141 (6): 413-20.
- Patel A, Mac Mahon S, Chalmers J et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-72.
- Intensive blood glucose control with sulphonil ureasor insulin compared with conventional treatment and risk of complications in patiemts with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study Group. Lancet 1998; 352 (9131): 837-53.
- Аметов А.С., Лысенко М.А. Сахарный диабет 2 типа и сердечно - сосудистые заболевания: столкновение двух глобальных неинфекционных эпидемий. РМЖ. 2011; 19 (12): 1-4.
- Jonsson B et al. Revealing the cost of Type II diabetes in Europe. Diabetologia 2002; 45: S5-S12.
- Aguiree Florencia, Brown Alex, Cho Nam Ho et al. IDF Diabetes Atlas: sixth edition - 2013.
- Дедов И.И., Шестакова М.В. Результаты реализации программы «Сахарный диабет». Сахарный диабет. 2013; 2.
- Хорошинина Л.П., Арьев А.Л. Диабетическая нефропатия и другие поздние осложнения сахарного диабета. СПб.: СПб МАПО, 2000.
- Bjork S. The cost of diabetes and diabetes care. Diabetes Res Clin 2001; 54 (Suppl. 1): S13-S18.
- The DECODE study group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Assiciation diagnostic criteria. Lancet 1999; 354: 617-21.
- Caswell M et al. Diabetes Tech Ther 2015; 17 (3): 1-6.
